Replies to post #2790 on NorthWest Biotherapeutics Inc (NWBO)

[nbinvest]

Finally showing a slow uptick

[koman]

Best regards to everyone. Until I find out the enrollment numbers to back up the 66events reported by NWBO, I consider the gbm pIII trial to be very risky at this point. Management's silence can only be interpreted as a bad thing until proven otherwise.